327 results on '"Konishi, Noboru"'
Search Results
2. Changes in lower urinary tract symptoms after iodine-125 brachytherapy for prostate cancer
3. CXCL1-Mediated Interaction of Cancer Cells with Tumor-Associated Macrophages and Cancer-Associated Fibroblasts Promotes Tumor Progression in Human Bladder Cancer
4. Characterization of liver-cirrhosis nodules by analysis of gene-expression profiles and patterns of allelic loss
5. ALKBH2, a novel AlkB homologue, contributes to human bladder cancer progression by regulating MUC1 expression
6. Cynomolgus monkey embryonic stem cell lines express green fluorescent protein
7. Inhibition of Heparanase Expression Results in Suppression of Invasion, Migration and Adhesion Abilities of Bladder Cancer Cells
8. Role of syndecan-1 (CD138) in cell survival of human urothelial carcinoma
9. Protein kinase Cγ, a protein causative for dominant ataxia, negatively regulates nuclear import of recessive-ataxia-related aprataxin
10. Syndecan-1, a new target molecule involved in progression of androgen-independent prostate cancer
11. Frequent LOH on 22q12.3 and TIMP-3 inactivation occur in the progression to secondary glioblastomas
12. Prostate cancer antigen-1 contributes to cell survival and invasion though discoidin receptor 1 in human prostate cancer
13. Expression and sub-cellular localization of human ABH family molecules
14. Specific positive and negative effects of FLIP on cell survival in human prostate cancer
15. Changes of Brain Endothelin Levels and Peripheral Endothelin Receptors by Chronic Cigarette Smoke in Spontaneously Hypertensive Rats
16. Phosphorylation of FADD is critical for sensitivity to anticancer drug-induced apoptosis
17. Hypermethylation-associated Inactivation of the SOCS-1 Gene, a JAK/STAT Inhibitor, in Human Pancreatic Cancers
18. Roles of p38- and c-jun NH2-terminal kinase-mediated pathways in 2-methoxyestradiol-induced p53 induction and apoptosis
19. Periodical assessment of genitourinary and gastrointestinal toxicity in patients who underwent prostate low-dose-rate brachytherapy
20. Specific Genomic Alterations in Rat Renal Cell Carcinomas Induced by N-Ethyl-N-hydroxyethylnitrosamine
21. 膀胱癌細胞株において、ヘパラナーゼを阻害することにより、細胞浸潤、遊走、接着能を抑制する
22. Minimal percentage of dose received by 90% of the urethra (%UD90) is the most significant predictor of PSA bounce in patients who underwent low-dose-rate brachytherapy (LDR-brachytherapy) for prostate cancer
23. Comparison of cancer detection rates by transrectal prostate biopsy for prostate cancer using two different nomograms based on patient’s age and prostate volume
24. ROS generation via NOX4 and its utility in the cytological diagnosis of urothelial carcinoma of the urinary bladder
25. Cyclooxygenase 2-dependent and independent activation of Akt through casein kinase 2α contributes to human bladder cancer cell survival
26. Ubiquilin 2 enhances osteosarcoma progression through resistance to hypoxic stress
27. Syndecan-1 responsive microRNA-126 and 149 regulate cell proliferation in prostate cancer
28. Additional file 5: Table S4. of Assessment of lower urinary symptom flare with overactive bladder symptom score and International Prostate Symptom Score in patients treated with iodine-125 implant brachytherapy: long-term follow-up experience at a single institute
29. Additional file 2: Table S1. of Assessment of lower urinary symptom flare with overactive bladder symptom score and International Prostate Symptom Score in patients treated with iodine-125 implant brachytherapy: long-term follow-up experience at a single institute
30. Additional file 4: Table S3. of Assessment of lower urinary symptom flare with overactive bladder symptom score and International Prostate Symptom Score in patients treated with iodine-125 implant brachytherapy: long-term follow-up experience at a single institute
31. Additional file 3: Table S2. of Assessment of lower urinary symptom flare with overactive bladder symptom score and International Prostate Symptom Score in patients treated with iodine-125 implant brachytherapy: long-term follow-up experience at a single institute
32. Additional file 7: Table S6. of Assessment of lower urinary symptom flare with overactive bladder symptom score and International Prostate Symptom Score in patients treated with iodine-125 implant brachytherapy: long-term follow-up experience at a single institute
33. Additional file 6: Table S5. of Assessment of lower urinary symptom flare with overactive bladder symptom score and International Prostate Symptom Score in patients treated with iodine-125 implant brachytherapy: long-term follow-up experience at a single institute
34. Inhibition of cell death and induction of G2 arrest accumulation in human ovarian clear cells by HNF-1β transcription factor: chemosensitivity is regulated by checkpoint kinase CHK1
35. ヒト食道扁平上皮癌におけるherpesvirus entry mediator関与の重要性
36. Phenotypic characterization of adenomyosis occurring at the inner and outer myometrium
37. Phosphorylation status of Fas-associated death domain protein is associated with biochemical recurrence after radical prostatectomy
38. ウサギ脊髄虚血モデルにおけるミノサイクリンの神経保護作用の評価
39. Additional file 2: Table S1. of Keratin 19 as a key molecule in progression of human hepatocellular carcinomas through invasion and angiogenesis
40. Additional file 1: Figure S1. of Keratin 19 as a key molecule in progression of human hepatocellular carcinomas through invasion and angiogenesis
41. Decreased renal α-Klotho expression in early diabetic nephropathy in humans and mice and its possible role in urinary calcium excretion
42. RETROPERITONEAL FIBROSARCOMA WITH DISTINCTIVE CHARACTERISTICS ON GROWTH P ATTERN AND FINDINGS IN DIAGNOSTIC IMAGING
43. Regulatory T Cells and Tumor-Associated Macrophages in the Tumor Microenvironment in Non-Muscle Invasive Bladder Cancer Treated with Intravesical Bacille Calmette-Guérin: A Long-Term Follow-Up Study of a Japanese Cohort
44. Diagnostic and prognostic role of urinary collagens in primary human bladder cancer
45. Trends in risk classification and primary therapy of Japanese patients with prostate cancer in Nara urological research and treatment group (NURTG) – comparison between 2004–2006, 2007–2009, and 2010–2012
46. Atypical small acinar proliferation and two or more cores of high-grade intraepithelial neoplasia on a previous prostate biopsy are significant predictors of cancer during a transperineal template-guided saturation biopsy aimed at sampling one core for each 1 mL of prostate volume
47. Comparison of PSA value at last follow-up of patients who underwent low-dose rate brachytherapy and intensity-modulated radiation therapy for prostate cancer
48. Assessment of lower urinary symptom flare with overactive bladder symptom score and International Prostate Symptom Score in patients treated with iodine-125 implant brachytherapy: long-term follow-up experience at a single institute
49. Transperineal template-guided saturation biopsy aimed at sampling one core for each milliliter of prostate volume: 103 cases requiring repeat prostate biopsy
50. Collagen type IV alpha 1 (COL4A1) and collagen type XIII alpha 1 (COL13A1) produced in cancer cells promote tumor budding at the invasion front in human urothelial carcinoma of the bladder
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.